Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2002) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.628 Q1 | 70 | 6 | 44 | 2012 | 229 | 44 | 5.62 | 335.33 |  |
| 2 | Pharmacological Reviews | journal | 12.251 Q1 | 254 | 23 | 64 | 6417 | 1857 | 63 | 27.44 | 279.00 |  |
| 3 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.158 Q4 | 50 | 6 | 206 | 1312 | 65 | 206 | 0.23 | 218.67 |  |
| 4 | Critical Reviews in Toxicology | journal | 1.344 Q1 | 129 | 16 | 61 | 2773 | 275 | 61 | 3.83 | 173.31 |  |
| 5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.976 Q1 | 82 | 15 | 42 | 2544 | 155 | 41 | 2.47 | 169.60 | |
| 6 | Natural Product Reports | journal | 2.877 Q1 | 211 | 43 | 114 | 7090 | 641 | 113 | 5.92 | 164.88 | |
| 7 | Progress in Medicinal Chemistry | journal | 1.175 Q1 | 38 | 11 | 21 | 1722 | 70 | 13 | 2.93 | 156.55 |  |
| 8 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.732 Q1 | 99 | 4 | 31 | 616 | 156 | 30 | 5.21 | 154.00 | |
| 9 | Current Cancer Drug Targets | journal | 0.495 Q2 | 103 | 20 | 16 | 3075 | 24 | 16 | 1.50 | 153.75 |  |
| 10 | Studies in Natural Products Chemistry | book series | 0.361 Q3 | 49 | 46 | 100 | 7039 | 59 | 55 | 0.59 | 153.02 | |
| 11 | Current Drug Metabolism | journal | 1.041 Q1 | 122 | 39 | 48 | 5619 | 144 | 45 | 3.00 | 144.08 | |
| 12 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 27 | 561 | 2 | 27 | 0.08 | 140.25 | | |
| 13 | Pharmacology and Therapeutics | journal | 2.731 Q1 | 233 | 66 | 203 | 9004 | 1437 | 200 | 6.15 | 136.42 | |
| 14 | Medicinal Research Reviews | journal | 1.869 Q1 | 150 | 26 | 84 | 3534 | 481 | 83 | 6.92 | 135.92 | |
| 15 | CNS and Neurological Disorders - Drug Targets | journal | 96 | 43 | 0 | 5827 | 0 | 0 | 0.00 | 135.51 | | |
| 16 | Current Pharmaceutical Biotechnology | journal | 0.635 Q1 | 97 | 26 | 52 | 3513 | 100 | 49 | 1.92 | 135.12 | |
| 17 | Annual Review of Pharmacology and Toxicology | journal | 10.266 Q1 | 224 | 23 | 78 | 2986 | 1814 | 77 | 20.70 | 129.83 | |
| 18 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.502 Q2 | 108 | 39 | 18 | 5020 | 22 | 18 | 1.22 | 128.72 | |
| 19 | Progress in Drug Research | book series | 0.618 Q1 | 46 | 14 | 45 | 1733 | 99 | 40 | 2.00 | 123.79 |  |
| 20 | Current Gene Therapy | journal | 0.350 Q3 | 80 | 34 | 24 | 4126 | 26 | 24 | 1.08 | 121.35 | |
| 21 | Current Drug Targets: Inflammation and Allergy | journal | 53 | 26 | 0 | 3033 | 0 | 0 | 0.00 | 116.65 | | |
| 22 | Current Topics in Medicinal Chemistry | journal | 0.414 Q3 | 133 | 82 | 40 | 8958 | 65 | 40 | 1.63 | 109.24 | |
| 23 | Drug Metabolism Reviews | journal | 1.060 Q1 | 108 | 34 | 88 | 3599 | 328 | 87 | 2.91 | 105.85 | |
| 24 | Current Medicinal Chemistry | journal | 2.023 Q1 | 202 | 147 | 263 | 15518 | 1518 | 241 | 4.99 | 105.56 | |
| 25 | Current Drug Targets | journal | 1.182 Q1 | 119 | 40 | 50 | 4034 | 145 | 46 | 2.90 | 100.85 | |
| 26 | Current Pharmaceutical Design | journal | 1.127 Q1 | 183 | 198 | 303 | 19253 | 1078 | 259 | 3.30 | 97.24 | |
| 27 | Expert Opinion on Emerging Drugs | journal | 0.270 Q3 | 54 | 25 | 68 | 2413 | 70 | 65 | 1.13 | 96.52 | |
| 28 | Expert Opinion on Therapeutic Targets | journal | 0.474 Q2 | 106 | 54 | 131 | 5107 | 108 | 131 | 1.04 | 94.57 | |
| 29 | Receptors and Channels | journal | 0.726 Q2 | 44 | 31 | 61 | 2887 | 82 | 59 | 1.03 | 93.13 | |
| 30 | Infectious Disorders - Drug Targets | journal | 0.284 Q3 | 61 | 30 | 27 | 2772 | 21 | 27 | 0.78 | 92.40 | |
| 31 | Expert Opinion on Investigational Drugs | journal | 0.790 Q1 | 117 | 134 | 790 | 12336 | 1907 | 769 | 2.57 | 92.06 | |
| 32 | Cellular and Molecular Life Sciences | journal | 3.180 Q1 | 261 | 196 | 592 | 18002 | 3218 | 573 | 5.21 | 91.85 | |
| 33 | Toxin Reviews | journal | 0.311 Q3 | 54 | 20 | 51 | 1741 | 54 | 47 | 0.78 | 87.05 | |
| 34 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.116 Q4 | 45 | 11 | 8 | 951 | 2 | 8 | 0.25 | 86.45 | |
| 35 | Annual Report of Shionogi Research Laboratory | journal | 0.104 Q4 | 2 | 1 | 5 | 86 | 1 | 5 | 0.33 | 86.00 |  |
| 36 | Clinical Pharmacokinetics | journal | 1.347 Q1 | 184 | 93 | 224 | 7889 | 1228 | 216 | 5.12 | 84.83 | |
| 37 | Drug Resistance Updates | journal | 1.060 Q1 | 132 | 24 | 141 | 2029 | 378 | 134 | 2.54 | 84.54 | |
| 38 | Pharmaceutical Biotechnology | journal | 0.918 Q1 | 28 | 16 | 17 | 1346 | 62 | 17 | 0.00 | 84.13 | |
| 39 | Mini-Reviews in Medicinal Chemistry | journal | 0.328 Q3 | 107 | 51 | 38 | 4269 | 40 | 38 | 1.05 | 83.71 | |
| 40 | BioDrugs | journal | 0.329 Q3 | 79 | 47 | 230 | 3842 | 264 | 217 | 1.44 | 81.74 | |
| 41 | Reviews in Contemporary Pharmacotherapy | journal | 0.403 Q2 | 18 | 4 | 38 | 311 | 78 | 38 | 2.09 | 77.75 | |
| 42 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 3 | 8 | 230 | 0 | 8 | 0.00 | 76.67 | | |
| 43 | Expert Opinion on Biological Therapy | journal | 0.575 Q2 | 102 | 92 | 84 | 7032 | 195 | 82 | 2.32 | 76.43 | |
| 44 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 52 | 153 | 3813 | 9 | 153 | 0.07 | 73.33 | |
| 45 | Neurotoxicity Research | journal | 0.265 Q3 | 84 | 63 | 46 | 4607 | 28 | 46 | 0.60 | 73.13 | |
| 46 | Advanced Drug Delivery Reviews | journal | 1.347 Q1 | 366 | 116 | 362 | 8443 | 1690 | 327 | 4.43 | 72.78 | |
| 47 | Expert Opinion on Pharmacotherapy | journal | 0.423 Q2 | 93 | 160 | 273 | 11187 | 453 | 263 | 1.70 | 69.92 | |
| 48 | CNS Drug Reviews | journal | 0.320 Q3 | 64 | 26 | 94 | 1806 | 91 | 94 | 1.50 | 69.46 | |
| 49 | American Journal of Respiratory Medicine | journal | 34 | 51 | 0 | 3419 | 0 | 0 | 0.00 | 67.04 | | |
| 50 | Drug Development Research | journal | 0.419 Q3 | 67 | 99 | 324 | 6376 | 393 | 316 | 1.25 | 64.40 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data